Viewing Study NCT06533033



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06533033
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: None
First Post: 2024-07-25

Brief Title: Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus
Sponsor: None
Organization: None

Study Overview

Official Title: Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus Epigenetic Randomized Clinical Trial
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background Oral Lichen planus OLP is one of the most common oral diseases that has an unneglectable rate of malignant transformation Recently malignant transformation has been definitively linked to epigenetic changes One of those most common changes is DNA hypermethylation that causes tumor suppressor genes to downtranslate and thus carcinogenesis begins ZNF582 gene hypermethylation is emerging as an exclusive biomarker to differentiate between normal and dysplastic changes that occur over the epithelium Aim To evaluate the Melatonin epigenetic potential in preventing malignant transformation of OLP Material and methods an epigenetic randomized clinical study will be conducted on 50 patients suffering from OLP recruited from the outpatient clinic of Oral medicine department Alexandria Faculty of Dentistry Egypt Patients will be assigned to either Control group who will receive topical corticosteroids and antifungal treatment or test group who will receive melatonin supplement in addition to conventional treatment All patients will be genetically evaluated for the level of DNA hypermethylation 8 weeks after treatment and clinically evaluated for disease severity and pain by Elsabagh scoring system 4 8 and 12 weeks after treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None